Intervention not reported
Non‐fatal MI (26 y) · health professionals from the USA and participants (“healthy volunteers from the Biobank cohort”) from the UK
The intervention showed no clear difference in non‐fatal MI (26 y) (low certainty).
1 finding from 1 review
HR 0.99 [0.89, 1.1]
43798 participants
Low
Intervention not reported
Stroke · health professionals from the USA and participants (“healthy volunteers from the Biobank cohort”) from the UK
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Peripheral artery disease · health professionals from the USA and participants (“healthy volunteers from the Biobank cohort”) from the UK
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Systolic blood pressure · health professionals from the USA and participants (“healthy volunteers from the Biobank cohort”) from the UK
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Type 2 diabetes (28 y) · health professionals from the USA and participants (“healthy volunteers from the Biobank cohort”) from the UK
The intervention may leads to higher type 2 diabetes (28 y) (low certainty).
1 finding from 1 review
HR 1.14 [1.07, 1.22]
71766 participants
Low
Intervention not reported
Cardiovascular mortality · healthy normal weighted participants recruited through leaflets from Italy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Systolic blood pressure · people with CKD
1 finding from 1 review
Diastolic blood pressure · people with CKD
1 finding from 1 review
Albuminuria · people with CKD
1 finding from 1 review
Extracellular fluid volume · people with CKD
1 finding from 1 review
Weight (kg) · people with CKD
1 finding from 1 review
Reduction in antihypertensive dose · people with CKD
It is very uncertain whether lower salt intake changes reduction in antihypertensive dose compared with higher salt intake (very low certainty).
1 finding from 1 review
Symptomatic hypotension · people with CKD
Lower salt intake probably leads to higher symptomatic hypotension compared with higher salt intake (moderate certainty).
1 finding from 1 review
Acute gout attacks · people with chronic gout
1 finding from 1 review
sUA reduction · participants with chronic gout and sUA level > 0.36mmol/L
1 finding from 1 review
Joint pain reduction ‐ not reported · participants with chronic gout and sUA level > 0.36mmol/L
The review found no eligible studies for this question.
1 finding from 1 review
Participant global assessment · participants with chronic gout and sUA level > 0.36mmol/L
The review found no eligible studies for this question.
1 finding from 1 review
Total adverse events · participants with chronic gout and sUA level > 0.36mmol/L
1 finding from 1 review
Tophus regression · participants with chronic gout and sUA level > 0.36mmol/L
The review found no eligible studies for this question.
1 finding from 1 review
Withdrawals due to adverse events · people with chronic gout
Skim milk enriched with GMP/G600 showed no clear difference in study withdrawals due to adverse events compared with skim milk, plus lactose powder (low certainty).